Co-payments for prescription drugs and the demand for doctor visits--evidence from a natural experiment

Health Economics
Rainer Winkelmann

Abstract

The German health care reform of 1997 provides a natural experiment for evaluating the price sensitivity of demand for physicians' services. As a part of the reform, co-payments for prescription drugs were increased step up to 200%. However, certain groups of people were exempted from the increase, providing a natural control group against which the changed demand for physicians' services of the treated, those subject to increased co-payments, can be assessed. The differences-in-differences estimates indicate that increased co-payments reduced the number of doctor visits by about 10% on an average.

References

Feb 15, 2003·The Rand Journal of Economics·Nina Pavenik

❮ Previous
Next ❯

Citations

Jul 15, 2006·The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care·Dag Morten DalenTonje Haabeth
Jun 28, 2006·The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care·Claudia Pütz, Christian Hagist
Sep 17, 2009·The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care·Jonas Schreyögg, Markus M Grabka
Feb 15, 2013·International Journal for Quality in Health Care : Journal of the International Society for Quality in Health Care·Jie Chen, Arturo Vargas-Bustamante
Apr 17, 2007·Journal of Epidemiology and Community Health·Lourdes LostaoPierre Aïach
Jul 13, 2013·BMC Health Services Research·Lars Eric Kroll, Thomas Lampert
May 6, 2008·International Journal for Equity in Health·Marin C GemmillElias Mossialos
Dec 19, 2008·Implementation Science : IS·Jane L HuttonJeremy M Grimshaw
Aug 31, 2013·The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care·Astrid Kiil, Kurt Houlberg
Nov 23, 2011·Journal of Health Economics·Maria TrottmannKonstantin Beck
Sep 28, 2015·Journal of Health Economics·Chao WangJeremiah Hurley
Oct 31, 2009·Arthritis and Rheumatism·Wei Zhang, Aslam H Anis
Feb 22, 2012·Health Economics·Christel E van DijkDinny H de Bakker
Jun 28, 2005·Journal of Health Economics·Rainer Winkelmann
Feb 25, 2015·Journal of Research in Pharmacy Practice·Peivand BastaniRasoul Dinarvand
Jul 17, 2016·Health Economics Review·Jana Votapkova, Pavlina Zilova
Feb 2, 2010·The Annals of Pharmacotherapy·Jie ChenAlexander N Ortega
Jan 24, 2018·Health Economics, Policy, and Law·Richard M Scheffler, Daniel R Arnold
Nov 11, 2019·The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care·Gretta Mohan, Anne Nolan
May 13, 2015·The Cochrane Database of Systematic Reviews·Vera Lucia LuizaAndrew D Oxman
Sep 12, 2014·European Journal of Gastroenterology & Hepatology·Mahiben MaruthappuHemant Sheth
Jun 19, 2013·Health Economics·Helmut Farbmacher, Joachim Winter
May 1, 2020·Archives of Iranian Medicine·Batool MousaviReza Majdzadeh
Jul 28, 2019·The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care·Laia MaynouMarc Saez

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.